Universal-Beteiligungs- und Servicegesellschaft’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328M Sell
1,523,584
-15,438
-1% -$3.42M 0.56% 23
2025
Q4
$348M Buy
1,539,022
+9,182
+0.6% +$2.09M 0.56% 20
2025
Q3
$354M Sell
1,529,840
-14,472
-0.9% -$2.95M 0.59% 18
2025
Q2
$287M Buy
1,544,312
+13,326
+0.9% +$2.48M 0.51% 27
2025
Q1
$321M Sell
1,530,986
-7,007
-0.5% -$1.36M 0.64% 19
2024
Q4
$273M Buy
+1,537,993
New +$283M 0.54% 24

Other funds holding ABBV

Universal-Beteiligungs- und Servicegesellschaft's ABBV Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its AbbVie (ABBV) stake by 1% in Q1 2026, selling an estimated $3.42M and leaving 1,523,584 shares worth $328M. The position accounts for 0.56% of the portfolio, ranked #23.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $354M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 1,523,584 shares of AbbVie worth $328M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 15,438 AbbVie shares in Q1 2026, an estimated $3.42M.
  • AbbVie made up 0.56% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #23 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's AbbVie position peaked at $354M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.